CDKN2A and melanoma: While p53 itself is only mutated in 19% of human melanomas, most human melanomas lose p53 pathway function due to other mutational events, including frequent loss of the CDKN2A locus, which encodes the ARF tumor suppressor, a regulator of p53 [22,23,24,25,26].